Biapenem/Vaborbactam

N/A

Report date: 2023/04/27 10:37:54

Base Information

Drug NameBiapenem/Vaborbactam
Drug Alias Name比阿培南/VaborbactamRPX7009/BiapenemVaborbactam/BiapenemVaborbactam and BiapenemBiapenem and Vaborbactam +[6] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBeta Lactamase inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBeta LactamaseBacterial penicillin-binding protein
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes BiapenemVaborbactam
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMelinta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMelinta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A